4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0000920465-14-000091
CIK 0000920465operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:31 PM ET
Size
5.6 KB
Accession
0000920465-14-000091
Insider Transaction Report
Form 4
Zarrabian Saiid
Director
Transactions
- Purchase
Common Stock
2014-07-31$9.53/sh+381$3,631→ 381 total(indirect: By Children)
Holdings
- 109,231
Common Stock
Footnotes (1)
- [F1]Represents the weighted-average price at which shares were purchased within a range between $9.52 and $9.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:31 PM ET
- Size
- 5.6 KB